The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 07, 2012
Filed:
Dec. 19, 2007
David A. Betebenner, Libertyville, IL (US);
Clarence J. Maring, Palatine, IL (US);
Todd W. Rockway, Grayslake, IL (US);
Curt S. Cooper, Vernon Hills, IL (US);
David D. Anderson, Groton, CT (US);
Rolf Wagner, Antioch, IL (US);
Rong Zhang, Niskayuna, NY (US);
Akhteruzzaman Molla, Gurnee, IL (US);
Hongmei MO, Foster City, CA (US);
Tami J. Pilot-matias, Green Oaks, IL (US);
Sherie V L. Masse, Kenosha, WI (US);
Robert J. Carrick, Pleasant Prairie, WI (US);
Wenping He, Libertyville, IL (US);
Liangjun LU, Kildeer, IL (US);
David A. Betebenner, Libertyville, IL (US);
Clarence J. Maring, Palatine, IL (US);
Todd W. Rockway, Grayslake, IL (US);
Curt S. Cooper, Vernon Hills, IL (US);
David D. Anderson, Groton, CT (US);
Rolf Wagner, Antioch, IL (US);
Rong Zhang, Niskayuna, NY (US);
Akhteruzzaman Molla, Gurnee, IL (US);
Hongmei Mo, Foster City, CA (US);
Tami J. Pilot-Matias, Green Oaks, IL (US);
Sherie V L. Masse, Kenosha, WI (US);
Robert J. Carrick, Pleasant Prairie, WI (US);
Wenping He, Libertyville, IL (US);
Liangjun Lu, Kildeer, IL (US);
Abbott Laboratories, Abbott Park, IL (US);
Abstract
Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.